XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes

14. INCOME TAXES:


We recorded income tax expense of $311,000 in the three months ended March 31, 2021, compared to income tax expense of $149,000 in the three months ended March 31, 2020. Our income tax expense in the three months ended March 31, 2021 reflected an effective tax rate of approximately 18%, compared to an effective tax rate of approximately 15% in the three months ended March 31, 2020. Our effective tax rate is impacted by the U.S. federal R&D tax credit and foreign tax credit. The increase in effective tax rate in the three months ended March 31, 2021 was primarily due to a reduction in the impact of the U.S. federal R&D tax credit and foreign tax credit on our effective tax rate due to the higher level of profitability expected in 2021. 


We have significant deferred tax assets as a result of temporary differences between taxable income on our tax returns and U.S. GAAP income, R&D tax credit carry forwards and state net operating loss carry forwards. A deferred tax asset generally represents future tax benefits to be received when temporary differences previously reported in our consolidated financial statements become deductible for income tax purposes, when net operating loss carry forwards could be applied against future taxable income, or when tax credit carry forwards are utilized on our tax returns. We assess the realizability of our deferred tax assets and the need for a valuation allowance based on the guidance provided in current financial accounting standards. 


Significant judgment is required in determining the realizability of our deferred tax assets. The assessment of whether valuation allowances are required considers, among other matters, the nature, frequency and severity of any current and cumulative losses, forecasts of future profitability, the duration of statutory carry forward periods, our experience with loss carry forwards not expiring unused and tax planning alternatives. In analyzing the need for valuation allowances, we first considered our history of cumulative operating results for income tax purposes over the past three years in each of the tax jurisdictions in which we operate, our financial performance in recent quarters, statutory carry forward periods and tax planning alternatives. In addition, we considered both our near-term and long-term financial outlook. After considering all available evidence (both positive and negative), we concluded that recognition of valuation allowances for substantially all of our U.S. and Singapore based deferred tax assets was not required at March 31, 2021 or December 31, 2020.


The Inland Revenue Authority of Singapore has initiated a routine compliance review of our 2018 income tax return. We presently anticipate that the outcome of this audit will not have a significant impact on our financial position or results of operations.